JENNIFER MILLSAP: Open Payments
NPI 1265927230 · ROSWELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,223 in 64 payments from 10 companies in 2025. Trend: 2023 $914 · 2024 $1,257 · 2025 $2,223
Food & beverage: $2,043Education: $180
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $645 |
| UCB, Inc. | 11 | $430 |
| ABBVIE INC. | 23 | $353 |
| Galderma Laboratories, L.P. | 10 | $344 |
| Arcutis Biotherapeutics, Inc. | 3 | $277 |
| Organon LLC | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| LEO Pharma Inc. | 1 | $23 |
| Botanix SB Inc | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $13 |
Products named: TREMFYA, Bimzelx, NEMLUVIO, SKYRIZI, Zoryve, VTAMA, COSENTYX, RINVOQ.
Industry payments across GA — which companies pay providers there.
